标题
Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation
作者
关键词
-
出版物
Nature Chemical Biology
Volume 13, Issue 1, Pages 38-45
出版商
Springer Nature
发表日期
2016-11-02
DOI
10.1038/nchembio.2211
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)
- (2014) Li Tan et al. JOURNAL OF MEDICINAL CHEMISTRY
- The fibroblast as a therapeutic target in rheumatoid arthritis
- (2013) Andrew Filer CURRENT OPINION IN PHARMACOLOGY
- Profiles of Basal and Stimulated Receptor Signaling Networks Predict Drug Response in Breast Cancer Lines
- (2013) M. Niepel et al. Science Signaling
- Cell type-specific function of TAK1 in innate immune signaling
- (2013) Adebusola A. Ajibade et al. TRENDS IN IMMUNOLOGY
- Discovery of Potent and Selective Covalent Inhibitors of JNK
- (2012) Tinghu Zhang et al. CHEMISTRY & BIOLOGY
- Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors
- (2012) Nunzio Bottini et al. Nature Reviews Rheumatology
- Targeting of TAK1 in inflammatory disorders and cancer
- (2012) Hiroaki Sakurai TRENDS IN PHARMACOLOGICAL SCIENCES
- Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor
- (2011) Derrick J. Todd et al. ARTHRITIS AND RHEUMATISM
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Comprehensive analysis of kinase inhibitor selectivity
- (2011) Mindy I Davis et al. NATURE BIOTECHNOLOGY
- Adaptive informatics for multifactorial and high-content biological data
- (2011) Bjorn L Millard et al. NATURE METHODS
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rheumatoid arthritis
- (2010) David L Scott et al. LANCET
- A Multitude of Kinases—Which are the Best Targets in Treating Rheumatoid Arthritis?
- (2010) Tamsin M. Lindstrom et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Rheumatoid arthritis progression mediated by activated synovial fibroblasts
- (2010) Elena Neumann et al. TRENDS IN MOLECULAR MEDICINE
- Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
- (2009) Beatrix Bartok et al. IMMUNOLOGICAL REVIEWS
- Synovial fibroblasts spread rheumatoid arthritis to unaffected joints
- (2009) Stephanie Lefèvre et al. NATURE MEDICINE
- Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis
- (2009) Peter C. Taylor et al. Nature Reviews Rheumatology
- IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
- (2008) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Is there a future for small molecule drugs in the treatment of rheumatic diseases?
- (2008) Joanna Stanczyk et al. CURRENT OPINION IN RHEUMATOLOGY
- The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis
- (2008) Erika H. Noss et al. IMMUNOLOGICAL REVIEWS
- Perturbational profiling of nanomaterial biologic activity
- (2008) S. Y. Shaw et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started